Dr. Kaur is acting CEO of ImmuneLink, LLC. She has served as faculty member in the Division of Oral Biology and Medicine at UCLA, School of Dentistry for 8 years. Dr. Kaur earned her Bachelor's in dental surgery degree from Baba Farid University of Health Sciences, Punjab, India in 2009, her Master in Science degree in Oral Biology/Oral Medicine at UCLA in 2015, and her Ph.D. with Dr. Anahid Jewett at UCLA in 2017. Dr. Kaur holds four patents, has published over 90 peer-reviewed scientific articles, 15+ book chapters, and reviewed over 2000 scientific articles in the field of cancer, immunology, and cancer therapeutics. She has served as co-principal investigator for phase I clinical trials https://clinicaltrials.gov/ct2/show/NCT03534115) at the UCLA School of Dentistry. She is also the Co-Principal investigator on several research grants at UCLA. Dr. Kaur has mentored and trained over 120 undergraduate/graduate/post-graduate students, dental students, dental clinicians, and medical doctors. Along with her teaching/research expertise, she is involved in various collaborative projects with investigators from other parts of the USA, and also other countries such as China, Slovenia, Poland, Japan, and Germany. Dr. Kaur also serves on the editorial board of more than 20 high-impact scientific journal in the field of Cancer and Immunology. She presented her work at more than 50 national and international conferences.